Bölümler
-
Practice Changing? 独断と偏見で選んだ注目演題について結果の予想も含めて議論しました。
-
Silke, Tom and Brian discuss what they are looking forward to at ASCO 2025
-
Eksik bölüm mü var?
-
日本と海外の違いはあるのか？mHSPCとmCRPCのUromigos Scoreについて激論！！
-
Silke and Chris joins us to discuss our latest 'Uromigos Score' in which experts score the value of treatments for advanced prostate cancer. Several interesting themes emerge.
-
Mark Tyson from Mayo Clinic joins the podcast to discuss this replicating adenovirus and a high CR rate in BCG-unresponsive NMIBC
-
Viktor Grunwald joins to discuss the new data session from EIKCS
-
Neal Shore joins the show to discuss these exciting data from the American Urological Association Annual Meeting
-
今月Eur Urol OncolにPublishされたヨーロッパのエキスパートによるmRCCのコンセンサスについて日本との違いについて深い議論をしました！！
-
Part 2 of our series dives deeper into the explosion of ADC clinical drug development in China
-
Drs. Dingwei Ye and Yao Zhu from China join the show to talk about drug development in China amid the recent surge of GU clinical trials.
-
Drs. Alicia Morgans and Chuck Ryan join the show to talk about their new podcast.
-
Ignacio Duran continues his discussion with Brian and Tom regarding novel ADCS in bladder cancer
-
Cristina Suárez analiza los próximos ensayos clínicos que podrían transformar el manejo del cáncer renal en los próximos años: nuevas combinaciones adyuvantes y estrategias perioperatorias, el uso de tripletes enprimera línea y la integración de inhibidores de HIF con TKIs, entre otros.
-
Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
-
Live from the Canary Islands 'Big Idea' talk from Tom, we discuss the new Uromigos Score which ranks different treatment options in several urothelial cancer settings.
-
Dr. John Heymach from MD Andersons joins us to discuss a novel PD1/VEGF bispecific agent in lung cancer and if there are applicaitons in GU malignancies.
-
Chuck Ryan joins us to discuss his interview with Felix and reflects on his keynote address at ASCO GU 2025.
- Daha fazla göster
